Articles tagged with Malaria
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers found that malaria parasites develop faster in mosquitoes at lower temperatures than previously thought, increasing the risk of transmission to millions of people worldwide. The study suggests that even slight climate warming could lead to greater increases in transmission risk.
High-resolution maps show progress in defeating malaria, but also highlight areas of stagnation and increased burden, particularly in Venezuela and sub-Saharan Africa. The research emphasizes the need for targeted interventions and sustained funding to overcome obstacles to eradication.
A new assay has been developed to detect patients' resistance to antimalarial drugs using whole blood, providing critical information quickly and efficiently in resource-limited settings. The technique eliminates DNA extraction steps, allowing for faster and more accurate assessment of genetic data associated with drug resistance.
Researchers at the University of Oxford have identified protective antibodies against malaria, which may lead to a highly effective vaccine. The study found that specific antibodies can block the malaria parasite's ability to bind to red blood cells.
A human liver cell protein called CXCR4 helps Plasmodium parasites develop into forms capable of infecting red blood cells. Targeting this protein may be a way to block the parasite's life cycle and prevent malaria development.
Researchers identified two P. falciparum-selective proteasome inhibitors with potent antimalarial activity against drug-resistant parasites. The inhibitors exhibited low propensity for generating resistance and synergized with multiple antimalarial agents.
Researchers at Clemson University have made significant progress in understanding the biology of Toxoplasma parasites, a human pathogen with high infection rates. By disrupting a key transporter, they were able to reduce the parasite's infectivity and provide insights into new targets for treatment.
Researchers have identified novel antigens on infected red blood cells that trigger natural human antibody responses, reducing malaria transmission. The discovery provides a promising alternative route for preventing disease spread and offers new leads for developing effective vaccines.
Researchers from Université Laval synthesized molecules discovered in a microscopic fungus from Nunavut, demonstrating their efficacy against malaria. The study found that the synthesized molecules, called mortiamides, stopped the growth of both parasite strains within 72 hours.
A transgenic fungus engineered to deliver a toxin to mosquitoes safely reduced mosquito populations by over 99% in a simulated village setting. The fungus is selective and won't harm beneficial species like honeybees, making it a promising new approach to controlling malaria.
The Q-Plex Human Malaria Array measures multiple malaria antigens in a single sample, improving diagnosis sensitivity and supporting public health surveillance. This tool can help researchers develop more accurate RDTs and assess their performance.
A new study by Stanford researchers found that investing in health aid uniquely improves the US's standing abroad, increasing favorability ratings and soft power. The study analyzed data from over 260,000 respondents in 45 low-to-middle-income countries between 2002 and 2016.
A study by ISGlobal and colleagues found that the RTS,S vaccine's protective effect increases with the strength of antibodies, not just their quantity. Children tend to have better protection due to higher avidity responses.
Scientists at the Francis Crick Institute and Imperial College London have identified novel compounds that target a different part of the malaria parasite's enzyme, evading the same resistance mechanism. This study aimed to prevent malaria treatment resistance by studying how it evolves during drug development.
A new study sheds light on the metabolic shifts that occur during chronic asymptomatic malaria infection, which can help develop more effective detection and treatment methods.
A new study reveals a wide variation in global malaria spending across 106 countries, with development assistance plateauing since 2010. The World Health Organization's annual funding target of $6.6 billion is still not met, and more resources are needed to bridge the $2.3 billion gap.
Researchers will assess whether mass treatment with primaquine can prevent relapses of Plasmodium vivax malaria along the borders of Thailand and Myanmar. The project aims to evaluate the safety and effectiveness of a preventive malaria treatment that could benefit up to 80% of the population.
Researchers are testing the RTS,S/AS01 vaccine, which provided partial protection against malaria in young children, in a pilot study in three countries. The goal is to vaccinate approximately 120,000 children annually and monitor its impact on preventing mortality from malaria.
A new study suggests that mass drug administration (MDA) can reduce malaria infections in communities where participation is high. The findings highlight the importance of approaching communities in an engaging and appropriate manner to encourage their involvement in MDA.
The study highlights the devastating impact of Venezuela's socioeconomic and political crisis on public health, with a significant increase in malaria cases. The country is now facing an 'epidemic of unprecedented proportions', with diseases turning into epidemics due to the collapse of healthcare systems.
A study by ISGlobal identifies West African regions where treating livestock with ivermectin can significantly impact malaria transmission. The analysis highlights the potential of this strategy to reduce malaria prevalence among children under 10 years of age and improve community health.
A new model predicts substantial reduction of malaria transmitting mosquitoes in West Africa by introducing genetically modified male mosquitoes with a driving-Y chromosome. The approach, which targets the most important species of malaria mosquitoes, has the potential to reduce populations and ultimately eliminate disease transmission.
A study by the London School of Hygiene & Tropical Medicine found that improved housing prevalence doubled from 11% to 23% in sub-Saharan Africa between 2000 and 2015. Despite this progress, 53 million urban Africans still lived in slum conditions in 2015.
The study found that the widely used antimalarial sulphadoxine-pyrimethamine (SP) is no longer effective in preventing malaria in areas with high levels of resistance. In areas where more than 37% of parasites carry six mutations, the effectiveness of SP appears to be fully compromised. The researchers are calling for further investiga...
Daniel Hartl receives the 2019 Thomas Hunt Morgan Medal for his influential contributions to experimental and theoretical genetics research, combining mathematical models with cutting-edge techniques. His work explains how DNA mutations are passed through generations, influencing species divergence.
A study by Liverpool School of Tropical Medicine found that complete window screening coverage was associated with a 92% reduction in malaria prevalence. Mosquito biting rates were also reduced, highlighting the potential impact of simple interventions on malaria transmission.
Researchers have pinpointed a single genetic alteration that confers resistance to pyrethroid insecticides in malaria-transmitting mosquitoes. The study provides a molecular diagnostic tool for detecting metabolic resistance and informs efforts to understand its spread across Africa.
A randomized trial of ivermectin mass administration in children aged five or younger shows a 20% reduction in malaria episodes without adverse events. The study suggests ivermectin could be a useful tool in disease reduction to combat residual transmission.
The study demonstrated that DSM265 can clear low-level Plasmodium falciparum parasitemia with a single oral dose. A companion drug is needed to prevent development of resistance and advance the goal of eradicating malaria.
Researchers have developed a method to use atovaquone-coated mosquito bed nets to cure mosquitoes and prevent malaria spread. The treatment could be more effective and less harmful than current methods.
A new vector control strategy is being developed by BOHEMIA, which uses ivermectin mass administration to kill malaria-transmitting mosquitoes. The project will conduct two clinical trials in Tanzania and Mozambique to evaluate the efficacy, safety, social science, and environmental impact of this approach.
Researchers found genetic evidence of malaria's emergence in Sub-Saharan Africa dating back to at least 20,000 years ago. The study challenges the long-held assumption that agriculture led to the spread of malaria.
Researchers found that treating bed nets with atovaquone can effectively reduce malaria transmission and mitigate insecticide resistance. The study showed that mosquitoes were completely blocked from developing Plasmodium falciparum, the parasite that causes malaria.
Experts warn of a surge in vector-borne diseases as Venezuela's humanitarian crisis worsens, with malaria cases increasing by 359% since 2010. The crisis is also leading to a resurgence of other diseases like Chagas disease and dengue, threatening public health gains in the country.
Scientists have discovered a new genus and species of mosquito in Myanmar amber dating back 100 million years, indicating that anopheline mosquitoes were present during this time period. This finding sheds light on the history of malaria and may offer clues on how its modern-day life cycle evolved.
Researchers analyzed gene expression profiles of P. vivax malaria patients to understand transmission and treatment response. The study revealed complex transmission dynamics and differences in how the parasite responds to chloroquine treatment.
The ESSENTIALS project aims to develop robust entomological indicators for assessing the public health value of new vector control tools, reducing the need for lengthy trials.
The study reveals that malaria parasite genomes are shaped by parasite-specific gene families and strongly correlate with virulence. The researchers identified unique features in the organization of gene families involved in antigenic variation, which enables high virulence in Plasmodium falciparum and Plasmodium knowlesi.
Researchers at Penn State have identified a complex of proteins crucial for the maturation of the malaria parasite's sexual stage, which is required for transmission to mosquitoes. Disrupting this complex inhibits the parasite's ability to mature and infect mosquitoes, offering a new tool in the fight against malaria.
A new malaria vaccine using a cytomegalovirus-based platform has shown promising results, reducing the parasite's release by 75-80% in infected rhesus macaques. The vaccine could offer lifelong protection against malaria, a disease that claims hundreds of millions of lives each year.
A recent review article suggests that understanding human behavior is crucial to preventing malaria transmission. Researchers found that while bed nets have been effective, they only work when people sleep under them, and there are gaps in knowledge about when and where people are exposed to malaria-transmitting mosquitoes at night.
Researchers at Karolinska Institutet reveal altered mosquito behavior and parasite selection as major obstacles to malaria eradication. The study shows a 96% decline in malaria incidence in Zanzibar, but highlights the need for new strategies to overcome challenges and achieve elimination.
A type of mosquito known to transmit malaria has been detected in Ethiopia for the first time, posing a public health concern. The Anopheles stephensi species was identified in Kebri Dehar, an eastern Ethiopian city, and its presence may lead to an emergence of malaria in new regions.
A new report highlights the need for effective communication in addressing 'post-normal' science technologies, such as gene drives, which pose a challenge to science journalists. The technology has the potential to reduce malaria deaths but also raises concerns about safety and regulation.
Researchers found that infected red blood cells from cerebral malaria patients bind more strongly to brain-derived cells than those from uncomplicated malaria patients. This suggests that specific PfEMP1 proteins on the infected red blood cells allow for efficient binding to brain vessels, a key feature of cerebral malaria.
A team of researchers from the University of Copenhagen has successfully completed a phase one clinical trial of their malaria vaccine, demonstrating its safety and ability to induce the desired antibody response in humans. The vaccine is now poised for further testing and potential use in vulnerable populations.
Researchers found pyronaridine-artesunate to be as effective as currently used artemisinin-based combination therapies for treating uncomplicated P. falciparum malaria. Mild liver injuries were observed in some patients but no severe damage was reported. The treatment holds promise for areas with rising artemisinin resistance.
ERADA's Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART) detects a unique biomarker from female parasites circulating in an infected individual. Early detection of malaria is crucial to eradication, as carriers are the reservoir that leads to infection and transmission.
Researchers at SUTD and NTU developed ferrocene-based molecules that impair malaria parasite's metabolic function, leading to parasite death. G3, a gold complexed ferrocinyl phosphine derivative, demonstrated potent antimalarial activity against standard and drug-resistant strains.
A new Ebola diagnostic test developed by David Sebba and colleagues offers a simple solution for detecting the disease in low-resource settings. The point-of-care test can distinguish between Ebola and other endemic diseases like Lassa fever and malaria within 30 minutes.
Researchers at Kanazawa University have discovered that a baculovirus can completely eliminate liver-stage malaria parasites in mice. The study suggests a new approach to developing non-haemolytic single-dose alternative drugs for P. vivax treatment, potentially reducing the risk of infection and side effects.
A new study by Johns Hopkins Center for Communication Programs finds that pregnant women and young children in sub-Saharan Africa are the most likely family members to sleep under bed nets to prevent malaria. The study suggests that providing enough bed nets can reduce age and gender disparities in net use, but highlights concerns abou...
Researchers developed a new approach to prevent malaria by targeting the parasite at an earlier stage in its lifecycle. They tested over 500,000 chemical compounds and identified 631 promising candidates that could form the basis for new drugs.
Researchers discovered that derivatives of amodiaquine can effectively block Ebola virus infection, with modified compounds showing improved potency and reduced toxicity. The findings offer a new therapeutic approach to treating patients infected with Ebola.
A recent study of amber-preserved blood-sucking insects and ticks reveals that malaria-causing microorganisms date back at least 100 million years, with evidence of pathogens carried by ancient vectors found in fossilized amber from around the world.
A new study reveals that Plasmodium falciparum parasites can directly convert from their asexual to sexual form without an additional replication cycle, increasing the parasite's survival and transmission capabilities. This finding provides important information on the malaria parasite's lifecycle and its transmission to mosquitoes.
A balanced pro and anti-inflammatory cytokine signature is associated with lower clinical malaria risk between ages 3-4. Early parasite exposure does not affect the risk, but may impact long-term immunity.
A new study published by Insilico Medicine using artificial intelligence has identified potential FP2 blockers, which could lead to the development of new antimalarial drugs. The research provides insights into the properties of E64 approaches and their interaction with falcipain-2, a key target for malaria treatment.
A study by ISGlobal and partners found that prenatal exposure to malaria significantly alters a newborn's innate immune response, particularly if the placenta is infected. This type of exposure may affect a baby's risk of developing malaria during their first year of life.
Karine Le Roch, a UC Riverside professor, is awarded two NIH grants totaling $6.6 million to study Plasmodium falciparum parasites and develop novel therapeutics. The research aims to target RNA-binding proteins, or RAPs, which are essential to parasite development.